Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
PHASE2
The purpose of this study is to estimate the rate of sustained virologic re...
Postmarketing Surveillance of the Safety and Effectiveness of Daclatasvir and Asunaprevir for the Treatment of Chronic HCV Genotype 1B Infection in the Routine Clinical Practice in Korea
N/A
The primary objective of this study is to describe the safety of the combin...
Status
Completed
Location
Local Institution
Start Date
2015-11-03
Trial ID
NCT02727933
The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure
PHASE4
Safety and Efficacy of DAAs (Daclatasvir+Asunaprevir) in patients with chro...